Allstate Corporation’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.9M | Buy |
212,477
+61,424
| +41% | +$3.58M | 0.14% | 90 |
|
|
2025
Q4 | $8.15M | Buy |
151,053
+76,582
| +103% | +$3.68M | 0.11% | 120 |
|
|
2025
Q3 | $3.36M | Buy |
+74,471
| New | +$3.48M | 0.08% | 143 |
|
|
2025
Q2 | – | Sell |
-73,667
| Closed | -$4.49M | – | 223 |
|
|
2025
Q1 | $4.49M | Buy |
73,667
+13,357
| +22% | +$779K | 0.13% | 96 |
|
|
2024
Q4 | $3.41M | Buy |
+60,310
| New | +$3.37M | 0.1% | 116 |
|
|
2024
Q3 | – | Sell |
-6,088
| Closed | -$253K | – | 124 |
|
|
2024
Q2 | $253K | Buy |
+6,088
| New | +$272K | 0.02% | 181 |
|
|
2024
Q1 | – | Sell |
-5,460
| Closed | -$280K | – | 228 |
|
|
2023
Q4 | $280K | Sell |
5,460
-1,117
| -17% | -$58.6K | 0.02% | 163 |
|
|
2023
Q3 | $382K | Hold |
6,577
| – | – | 0.02% | 126 |
|
|
2023
Q2 | $421K | Sell |
6,577
-238
| -3% | -$16K | 0.03% | 126 |
|
|
2023
Q1 | $472K | Sell |
6,815
-103,714
| -94% | -$7.32M | 0.04% | 107 |
|
|
2022
Q4 | $7.95M | Buy |
110,529
+482
| +0.4% | +$36.3K | 0.24% | 57 |
|
|
2022
Q3 | $7.82M | Sell |
110,047
-618
| -0.6% | -$44.8K | 0.23% | 58 |
|
|
2022
Q2 | $8.52M | Sell |
110,665
-30,614
| -22% | -$2.33M | 0.26% | 47 |
|
|
2022
Q1 | $10.3M | Sell |
141,279
-67,275
| -32% | -$4.52M | 0.28% | 46 |
|
|
2021
Q4 | $13M | Buy |
208,554
+163,747
| +365% | +$9.61M | 0.25% | 68 |
|
|
2021
Q3 | $2.65M | Sell |
44,807
-3,654
| -8% | -$241K | 0.11% | 89 |
|
|
2021
Q2 | $3.24M | Sell |
48,461
-3,125
| -6% | -$204K | 0.11% | 77 |
|
|
2021
Q1 | $3.26M | Buy |
51,586
+444
| +0.9% | +$27.6K | 0.1% | 83 |
|
|
2020
Q4 | $3.17M | Buy |
51,142
+4,282
| +9% | +$263K | 0.1% | 72 |
|
|
2020
Q3 | $2.83M | Sell |
46,860
-18,711
| -29% | -$1.13M | 0.09% | 70 |
|
|
2020
Q2 | $3.86M | Buy |
65,571
+8,550
| +15% | +$511K | 0.13% | 62 |
|
|
2020
Q1 | $3.18M | Sell |
57,021
-81,744
| -59% | -$5M | 0.12% | 64 |
|
|
2019
Q4 | $8.91M | Buy |
138,765
+111,153
| +403% | +$6.37M | 0.16% | 73 |
|
|
2019
Q3 | $1.4M | Sell |
27,612
-121,778
| -82% | -$5.72M | 0.02% | 340 |
|
|
2019
Q2 | $6.78M | Buy |
149,390
+64,551
| +76% | +$3.01M | 0.12% | 86 |
|
|
2019
Q1 | $4.05M | Sell |
84,839
-25,098
| -23% | -$1.25M | 0.11% | 134 |
|
|
2018
Q4 | $5.71M | Buy |
+109,937
| New | +$5.91M | 0.19% | 82 |
|
|
2016
Q4 | – | Sell |
-74,823
| Closed | -$4.03M | – | 203 |
|
|
2016
Q3 | $4.03M | Buy |
+74,823
| New | +$4.81M | 0.28% | 92 |
|
|
2013
Q3 | – | Sell |
-137,264
| Closed | -$6.13M | – | 136 |
|
|
2013
Q2 | $6.13M | Buy |
+137,264
| New | +$5.96M | 0.28% | 76 |
|
Other funds holding BMY
VCM
VPM
Allstate Corporation's BMY Position: Q1 2026 in Review
Allstate Corporation increased its Bristol-Myers Squibb (BMY) stake by 41% in Q1 2026, buying an estimated $3.58M and bringing the position to 212,477 shares worth $12.9M. The position accounts for 0.14% of the portfolio, ranked #90.
Allstate Corporation first reported a position in BMY in Q2 2013 and has held it in 29 quarters since. The position peaked at $13M in Q4 2021. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Allstate Corporation held 212,477 shares of Bristol-Myers Squibb worth $12.9M as of Q1 2026.
- Allstate Corporation bought 61,424 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.58M.
- Bristol-Myers Squibb made up 0.14% of Allstate Corporation's portfolio in Q1 2026, its #90 holding.
- Allstate Corporation first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 29 quarters since.
- Allstate Corporation's Bristol-Myers Squibb position peaked at $13M in Q4 2021.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.